Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06676995 · ClinicalTrials.gov registry record · NA
Effects of Transcranial Pulse Stimulation in Parkinson's Disease
A NA study, sponsored by Spaulding Rehabilitation Hospital.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT06676995 is a NA study that has completed, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 14 participants.
The verdict
NCT06676995, a NA study, has completed, sponsored by Spaulding Rehabilitation Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The investigators are studying if Transcranial Pulse Stimulation (TPS) can improve various symptoms, including movement problems, thinking abilities, mood, fatigue, freezing while walking, voice quality, and issues with smell and taste. Previous research suggests TPS might help in Alzheimer's disease and could be helpful for Parkinson's as well. Investigators will check if TPS is safe, practical, and if it makes a noticeable difference in these symptoms compared to before the treatment.
Interventions
- DEVICE Transcranial Pulse Stimulation (TPS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2024-12-31 |
| Est. Completion | 2025-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06676995
The ClinicalTrials.gov registry entry for NCT06676995 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Spaulding Rehabilitation Hospital, which has 101 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcranial Pulse Stimulation (TPS) is the first listed.
NCT06676995 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06676995 about?
NCT06676995 is a clinical study titled "Effects of Transcranial Pulse Stimulation in Parkinson's Disease". The investigators are studying if Transcranial Pulse Stimulation (TPS) can improve various symptoms, including movement problems, thinking abilities, mood, fatigue, freezing while walking, voice quality, and issues with smell and taste. Previous research suggests TPS might help in Alzheimer's diseas...
What is the current status of trial NCT06676995?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2024-12-31. Estimated completion is 2025-07-30.
What interventions are being tested in trial NCT06676995?
The interventions under investigation include: Transcranial Pulse Stimulation (TPS) (DEVICE).
Who is sponsoring clinical trial NCT06676995?
This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.